Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Offermann

Showing results (131-140 of 134) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 134 results.
Deutsche Medizinische Wochenschrift (1946)|February 24, 1984
[Trial for digitalis withdrawal in hemodialysis patients]F Keller, A Schwarz, G Offermann, et al.
Nephron|January 1, 1990
Soluble interleukin 2 receptor and tissue polypeptide antigen serum concentrations in end-stage renal failureG Walz, U Kunzendorf, O Josimovic-Alasevic, et al.
Artificial Organs|November 1, 1978
Chronic hemofiltration. A critical evaluation of a new method for the treatment of bloodK Schaefer, D von Herrath, C A Gullberg, et al.
The Pharmacogenomics Journal|January 9, 2008
CYP3A5 genotype is associated with longer patient survival after kidney transplantation and long-term treatment with cyclosporineR Kreutz, J Bolbrinker, F van der Sman-de Beer, et al.
Pageof 14

Showing results (131-140 of 134) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 134 results.
Deutsche Medizinische Wochenschrift (1946)|February 24, 1984
[Trial for digitalis withdrawal in hemodialysis patients]F Keller, A Schwarz, G Offermann, et al.
Nephron|January 1, 1990
Soluble interleukin 2 receptor and tissue polypeptide antigen serum concentrations in end-stage renal failureG Walz, U Kunzendorf, O Josimovic-Alasevic, et al.
Artificial Organs|November 1, 1978
Chronic hemofiltration. A critical evaluation of a new method for the treatment of bloodK Schaefer, D von Herrath, C A Gullberg, et al.
The Pharmacogenomics Journal|January 9, 2008
CYP3A5 genotype is associated with longer patient survival after kidney transplantation and long-term treatment with cyclosporineR Kreutz, J Bolbrinker, F van der Sman-de Beer, et al.
Pageof 14